Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1881-1890

  Duan, Li Juan ^a   Takeda, Kotaro ^a   Fong, Guo Hua ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE DOMAIN PROTEIN 2; UNCLASSIFIED DRUG;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HYPEROXIA; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETINOPATHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 79953644844     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.016     Document Type: Article

References (43)

1. Chen M, Citil A, McCabe F, Leicht KM, Fiascone J, Dammann CE, Dammann O: Infection. Oxygen, and immaturity: interacting risk factors for retinopathy of prematurity Neonatology 2010, 99:125-132
2. Smith LE: Pathogenesis of retinopathy of prematurity. Semin Neonatol 2003, 8:469-473
3. Heidary G, Vanderveen D, Smith LE: Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol 2009, 24:77-81
4. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111 (Pubitemid 24046832)
5. Arjamaa O, Nikinmaa M: Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp Eye Res 2006, 83:473-483 (Pubitemid 43902768)
6. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL: Dimerization. DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996, 271:17771-17778 (Pubitemid 26250751)
7. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y: A novel bHLH-PAS factor with close sequence similarity to hypoxiainducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 1997, 94:4273-4278
8. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16:4604-4613 (Pubitemid 26272112)
9. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA: An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A 2009, 106:18751-18756
10. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro PA, Semenza GL: Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003, 93:1074-1081 (Pubitemid 37485038)
11. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864 (Pubitemid 39070860)
12. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12:5447-5454
13. Kertesz N, Wu J, Chen TH, Sucov HM, Wu H: The role of erythropoietin in regulating angiogenesis. Dev Biol 2004, 276:101-110 (Pubitemid 39452849)
14. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 107:43-54 (Pubitemid 32972036)
15. Bruick RK, McKnight SL: A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340 (Pubitemid 33063099)
16. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K, Yang H, Sorokina I, Conaway RC, Conaway JW, Kaelin WG Jr: Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci U S A 2002, 99:13459-13464 (Pubitemid 35215403)
17. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein PVHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275 (Pubitemid 29246458)
18. Sutter CH, Laughner E, Semenza GL: Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquiti-nation that is disrupted by deletions and missense mutations. Proc Natl Acad Sci U S A 2000, 97:4748-4753 (Pubitemid 30238629)
19. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L: Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitinproteasome pathway. J Biol Chem 1999, 274:6519-6525 (Pubitemid 29111068)
20. Semenza GL: Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood 2009, 114:2015-2019
21. Fong GH: Regulation of angiogenesis by oxygen sensing mechanisms. J Mol Med 2009, 87:549-560
22. Myllyharju J: HIF prolyl 4-hydroxylases and their potential as drug targets. Curr Pharm Des 2009, 15:3878-3885
23. Fandrey J, Gassmann M: Oxygen sensing and the activation of the hypoxia inducible factor 1 (HIF-1) - invited article. Adv Exp Med Biol 2009, 648:197-206
24. Uno K, Prow TW, Bhutto IA, Yerrapureddy A, McLeod DS, Yamamoto M, Reddy SP, Lutty GA: Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy. Exp Eye Res 2010, 90:493-500
25. Byfield G, Budd S, Hartnett ME: The role of supplemental oxygen and JAK/STAT signaling in intravitreous neoangiogenesis in a ROP rat model. Invest Ophthalmol Vis Sci 2009, 50:3360-3365
26. Hardy P, Dumont I, Bhattacharya M, Hou X, Lachapelle P, Varma DR, Chemtob S: Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res 2000, 47:489-509 (Pubitemid 30646071)
27. Takeda K, Cowan A, Fong GH: Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 2007, 116:774-781 (Pubitemid 47255995)
28. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH: Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol 2006, 26:8336-8346 (Pubitemid 44748568)
29. Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE: Quantification of oxygeninduced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 2009, 4:1565-1573
30. Minamishima YA, Moslehi J, Padera RF, Bronson RT, Liao R, Kaelin WG Jr: A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo, Mol Cell Biol 2009, 29:5729-5741
31. Aprelikova O, Chandramouli GV, Wood M, Vasselli JR, Riss J, Maranchie JK, Linehan WM, Barrett JC: Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem 2004, 92:491-501
32. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P, Metzen E: Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alphaprolyl-4-hydroxylases. Biochem J 2004, 381:761-767 (Pubitemid 39120486)
33. Stiehl DP, Wirthner R, Koditz J, Spielmann P, Camenisch G, Wenger RH: Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygensensing system. J Biol Chem 2006, 281:23482-23491 (Pubitemid 44274123)
34. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995, 270:19761-19766
35. Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA, Melamed J, Semenza GL: Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 2005, 65:6178-6188 (Pubitemid 40994403)
36. Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC: Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 2007, 104:2301-2306 (Pubitemid 46391392)
37. Mowat FM, Luhmann UF, Smith AJ, Lange C, Duran Y, Harten S, Shukla D, Maxwell PH, Ali RR, Bainbridge JW: HIF-1alpha and HIF- 2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS One 2010, 5:e11103
38. Sears JE, Hoppe G, Ebrahem Q, Anand-Apte B: Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy. Proc Natl Acad Sci U S A 2008, 105:19898-19903
39. Lofqvist C, Chen J, Connor KM, Smith AC, Aderman CM, Liu N, Pintar JE, Ludwig T, Hellstrom A, Smith LE: IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A 2007, 104:10589-10594 (Pubitemid 47185709)
40. Chang KH, Chan-Ling T, McFarland EL, Afzal A, Pan H, Baxter LC, Shaw LC, Caballero S, Sengupta N, Li Calzi S, Sullivan SM, Grant MB: IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci U S A 2007, 104:10595-10600 (Pubitemid 47185710)
41. Kojima H, Otani A, Oishi A, Makiyama Y, Nakagawa S, Yoshimura N: Granulocyte colony-stimulating factor attenuates oxidative stress-induced apoptosis in vascular endothelial cells and exhibits functional and morphological protective effect in oxygen-induced retinopathy. Blood 2010 117:1091-1100
42. Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O, Kawauchi S, Ema M, Shibahara S, Udono T, Tomita K, Tamai M, Sogawa K, Yamamoto M, Fujii-Kuriyama Y: HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 2003, 22:1134-1146 (Pubitemid 36313597)
43. Dioum EM, Clarke SL, Ding K, Repa JJ, Garcia JA: HIF-2alpha- haploinsufficient mice have blunted retinal neoangiogenesis due to impaired expression of a proangiogenic gene battery. Invest Ophthalmol Vis Sci 2008, 49:2714-2720